Decree Includes Key Provisions Aimed to Prioritize Patient Relief and Ensure Company's Regulatory Compliance "The finalization of this decree is a significant milestone. Throughout this recall, we ...
Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. This story was co-published with the Pittsburgh Post-Gazette.
This article originally appeared in ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. For ...
Philips has reached a $1.1 billion agreement to settle claims from about 58,000 people stemming from its yearslong recall of home CPAP ventilators and sleep apnea machines. It’s a major milestone in ...
Adding additional wounds to Philips bruising few years dealing with its major recall of CPAP and BiPAP machines, a new issue has arisen in a swath of its CPAP machines not included in the 2021 notice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results